Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) Bitcoin USD
68,111.29 +1,201.11 (+1.80%) CMC Crypto 200
1,380.37 +49.77 (+3.74%)
Organigram Holdings Inc. (OGI.TO)
| Previous close | 2.2400 |
| Open | 2.2500 |
| Bid | 2.2400 x N/A |
| Ask | 2.2800 x N/A |
| Day's range | 2.2300 - 2.2850 |
| 52-week range | 1.3500 - 3.9500 |
| Volume | |
| Avg. volume | 237,560 |
| Market cap | 232.263M |
| Beta (5Y monthly) | 1.10 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Reuters
US, Canadian pot firms eye Germany for growth as market stagnates at home
North American cannabis firms, facing prohibitive laws, an overcrowded market and a deeply entrenched illicit sector at home are ramping up investments in Germany after the country partly legalized marijuana use. Germany, the largest medical cannabis market in Europe, decriminalized cannabis possession and small-scale home cultivation in April, making it easier for doctors to prescribe it. But only a few local companies are licensed to grow pot, and U.S. and Canadian firms are looking to capture a slice of the market by providing capital and exporting products to Germany.
- Zacks
Are Medical Stocks Lagging OrganiGram (OGI) This Year?
Here is how OrganiGram (OGI) and ResMed (RMD) have performed compared to their sector so far this year.
- Zacks
Why OrganiGram (OGI) Might Surprise This Earnings Season
OrganiGram (OGI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
